Avotres is a biotechnology company that is developing novel therapeutics for incurable immunologically mediated diseases. In these therapeutic areas with significant unmet medical needs, they use cutting-edge science to uncover potentially paradigm-shifting immunological pathways in they improving the lives of millions of patients. AVT002, amonoclonal antibody, is also being developed as a potential cancer therapy directed at a novel immuno-oncology target.

Biotechnology

Health Care

Avotres Inc.

Org chart

Similar companies